For a free DePuy lawsuit consultation, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454.
Austin, Texas (PRWEB) January 20, 2014
A Case Management Conference has been scheduled for January 29, 2014 to address DePuy ASR hip lawsuits pending in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, Hissey Kientz, LLP reports. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11) According to an article published on November 19, 2013 in the New York Times, the DePuy Orthopaedics division of Johnson & Johnson could pay $4 billion to settle thousands of DePuy ASR hip replacement lawsuits.*
Johnson & Johnson is currently facing nearly 12,000 DePuy lawsuits filed in federal courts and state courts in California, Illinois and New Jersey. Johnson & Johnson has already agreed to a settlement amount of at least $2.47 billion to resolve approximately 8,000 DePuy lawsuits filed by patients who had to have their hip replacement surgically removed.**
DePuy lawsuits were filed after Johnson & Johnson issued a recall of 93,000 DePuy ASR hip implants worldwide in August 2010, reporting that 12 percent failed within five years. DePuy hip replacement complications can include hip implant loosening, metal poisoning from elevated cobalt and chromium levels, fractures at the site of the implant and dislocation of the hip device. ***
Patients who have experienced side effects from a DePuy hip replacement may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For a free DePuy lawsuit consultation, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.
About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents patients who received recalled DePuy hip replacements, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa and Effexor, GranuFlo and NaturaLyte acid concentrates, Stryker and BioMet hip replacements, transvaginal mesh implants, Mirena IUDs and other defective drugs and medical devices.